Should patients with high-risk prostate cancer receive 6 months or 3 years of adjuvant androgen suppression therapy?
Strope
Seth
S
Department of Urology, University of Michigan, Ann Arbor, MI 48104-0330, USA. sethstro@med.umich.edu
Wood
David P
DP